Position in EXEL
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$37,743
New position
Shares Held
880
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026MCF Advisors LLC holds $667,948 across 23 Biotechnology names. EXEL ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EYPT |
EyePoint, Inc.
|
13,420 | $172,983 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
2,187 | $104,035 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
197 | $87,968 | |
| 4 | MNKD |
Mannkind Corp
|
25,110 | $61,519 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
462 | $42,679 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
880 | $37,743 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42 | $32,450 | |
| 8 | CMPX |
Compass Therapeutics, Inc.
|
5,540 | $29,306 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,743 | 880 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||